Jim Simons Ocugen, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.36 - $0.57 $242,992 - $384,737	-674,978 Reduced 73.28%	246,173 $142,000
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $620,002 - $961,003	-1,550,005 Reduced 62.72%	921,151 $368,000
Q2 2023 Aug 11, 2023	BUY	$0.45 - $0.88 $85,323 - $166,855	189,608 Added 8.31%	2,471,156 $1.34 Million
Q1 2023 May 12, 2023	BUY	$0.82 - $1.33 $704,127 - $1.14 Million	858,692 Added 60.35%	2,281,548 $1.95 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.87 $1.58 Million - $2.66 Million	1,422,856 New	1,422,856 $1.85 Million
Q2 2022 Aug 12, 2022	BUY	$1.83 - $3.45 $1.14 Million - $2.15 Million	621,856 New	621,856 $1.41 Million
Q4 2021 Feb 11, 2022	SELL	$4.38 - $15.67 $49,301 - $176,381	-11,256 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.36 - $8.51 $15.5 Million - $20.7 Million	-2,429,500 Reduced 99.54%	11,256 $81,000
Q2 2021 Aug 13, 2021	BUY	$5.52 - $15.68 $13.5 Million - $38.3 Million	2,440,756 New	2,440,756 $19.6 Million
Q3 2020 Nov 13, 2020	SELL	$0.2 - $0.72 $55,933 - $201,361	-279,669 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.22 - $0.46 $89,725 - $187,608	-407,845 Reduced 59.32%	279,669 $62,000
Q1 2020 May 14, 2020	BUY	$0.26 - $0.73 $175,633 - $493,125	675,514 Added 5629.28%	687,514 $193,000
Q4 2019 Feb 13, 2020	BUY	$0.27 - $2.19 $3,240 - $26,280	12,000 New	12,000 $6,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.